CBIS.OB Cannabis Science Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CBIS.OB Cannabis Science

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gersh Avery	1/20/2011 11:15:21 PM
	of 27

January 20, 2011 - Madrid, Spain Madrid, Spain: The combined administration of THC and the pharmaceutical agent temozolomide (TMZ) demonstrates strong anti-cancer activity in brain tumors resistant to conventional anti-cancer treatments, according to preclinical data published online in the journal Molecular Cancer Therapeutics. Investigators at Complutense University in Spain assessed the anti-tumor activity of the cannabinoids THC and CBD (cannabidiol) in glioma xenografts (tissue grafts). Authors reported that the administration of THC in combination with TMZ (the benchmark agent for the management of glioblastoma) "enhanced autophagy" (programmed cell death) in malignant tissue. The combined administration of THC, CBD, and TMZ "remarkably reduce[d] the growth of glioma xenografts ... [and] produced a strong antitumoral action in both TMZ-sensitive and TMZ-resistant tumors." snip -- more here: norml.org

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next